Alex H Gifford

7PUBLICATIONS
16CO-AUTHORS
Infant and child healthMedical molecular engineering of nucleic acids and proteinsPacific Peoples cultural determinants of healthCarbon capture engineering (excl. sequestration)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 12, 2026
Utilization of Des-Gamma-Carboxy-Prothrombin in Estimating Vitamin K Status in People With Cystic Fibrosis: A Single Center Retrospective Review.

|Jul 22, 2025
Improving Modulator Management and Side Effect Screening: A CF Learning Network Innovation Lab.

Kevin P Lonabaugh, Anna Saulitis, Elizabeth Boettinger

|Apr 16, 2021
Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis.

Alex H Gifford, Julie L Sanville, Meghana Sathe

|Jan 19, 2021
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design.

Nicole Mayer-Hamblett, David P Nichols, Katherine Odem-Davis

|Dec 25, 2018
CFTR Modulator Use Is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis.

Alex H Gifford, Sonya L Heltshe, Christopher H Goss

Pageof 2

Frequent Collaborators

1 joint publications

Sonya L Heltshe

1 joint publications

Christopher H Goss

1 joint publications

Nicole Mayer-Hamblett

1 joint publications

David P Nichols